Ryan E Berecky, MD | |
1460 Ne Medical Center Dr, Bend, OR 97701-6061 | |
(541) 382-6633 | |
(541) 382-2719 |
Full Name | Ryan E Berecky |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 17 Years |
Location | 1460 Ne Medical Center Dr, Bend, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104026772 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | MD156397 (Oregon) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Charles Medical Center - Bend | Bend, OR | Hospital |
St Charles Prineville | Prineville, OR | Hospital |
Wallowa Memorial Hospital | Enterprise, OR | Hospital |
Harney District Hospital | Burns, OR | Hospital |
Pioneer Memorial Hospital (heppner) | Heppner, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Morrow County Health District | 2365359296 | 43 |
Central Oregon Magnetic Resonance Imaging Llc | 8224058003 | 27 |
Central Oregon Radiology Assoc Pc | 9335132091 | 35 |
Cascade Medical Imaging Llc | 9537140108 | 29 |
News Archive
With only incremental improvements in ovarian cancer survival over the last 40 years, there is a clear need for new treatment options with long-lasting results. Many researchers have turned toward the development of immunotherapies that direct T-cells to selectively eliminate ovarian tumor cells, but an appropriate therapeutic target for ovarian cancers has remained elusive.
In the context of ongoing budget talks, House Democrats urged President Barack Obama to maintain the Medicare program and stand firm against Republican efforts to cut the program's spending.
Researchers at The Queensland Institute of Medical Research (QIMR) have found that drugs used to treat HIV Aids may also be effective against the biggest killer in the world - malaria.
Through a few clever molecular hacks, researchers at Columbia University Medical Center have converted a natural bacterial immune system into a microscopic data recorder, laying the groundwork for a new class of technologies that use bacterial cells for everything from disease diagnosis to environmental monitoring.
Novartis announced today that Tafinlar (dabrafenib) + Mekinist (trametinib), the first oral combination therapy to be licensed for advanced melanoma, is now available in the UK for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.
› Verified 4 days ago
Entity Name | Morrow County Health District |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770514481 PECOS PAC ID: 2365359296 Enrollment ID: O20040226001024 |
News Archive
With only incremental improvements in ovarian cancer survival over the last 40 years, there is a clear need for new treatment options with long-lasting results. Many researchers have turned toward the development of immunotherapies that direct T-cells to selectively eliminate ovarian tumor cells, but an appropriate therapeutic target for ovarian cancers has remained elusive.
In the context of ongoing budget talks, House Democrats urged President Barack Obama to maintain the Medicare program and stand firm against Republican efforts to cut the program's spending.
Researchers at The Queensland Institute of Medical Research (QIMR) have found that drugs used to treat HIV Aids may also be effective against the biggest killer in the world - malaria.
Through a few clever molecular hacks, researchers at Columbia University Medical Center have converted a natural bacterial immune system into a microscopic data recorder, laying the groundwork for a new class of technologies that use bacterial cells for everything from disease diagnosis to environmental monitoring.
Novartis announced today that Tafinlar (dabrafenib) + Mekinist (trametinib), the first oral combination therapy to be licensed for advanced melanoma, is now available in the UK for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.
› Verified 4 days ago
Entity Name | Central Oregon Radiology Assoc Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477590081 PECOS PAC ID: 9335132091 Enrollment ID: O20040407000799 |
News Archive
With only incremental improvements in ovarian cancer survival over the last 40 years, there is a clear need for new treatment options with long-lasting results. Many researchers have turned toward the development of immunotherapies that direct T-cells to selectively eliminate ovarian tumor cells, but an appropriate therapeutic target for ovarian cancers has remained elusive.
In the context of ongoing budget talks, House Democrats urged President Barack Obama to maintain the Medicare program and stand firm against Republican efforts to cut the program's spending.
Researchers at The Queensland Institute of Medical Research (QIMR) have found that drugs used to treat HIV Aids may also be effective against the biggest killer in the world - malaria.
Through a few clever molecular hacks, researchers at Columbia University Medical Center have converted a natural bacterial immune system into a microscopic data recorder, laying the groundwork for a new class of technologies that use bacterial cells for everything from disease diagnosis to environmental monitoring.
Novartis announced today that Tafinlar (dabrafenib) + Mekinist (trametinib), the first oral combination therapy to be licensed for advanced melanoma, is now available in the UK for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.
› Verified 4 days ago
Entity Name | Lake Health District |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376698522 PECOS PAC ID: 4284629221 Enrollment ID: O20040419000549 |
News Archive
With only incremental improvements in ovarian cancer survival over the last 40 years, there is a clear need for new treatment options with long-lasting results. Many researchers have turned toward the development of immunotherapies that direct T-cells to selectively eliminate ovarian tumor cells, but an appropriate therapeutic target for ovarian cancers has remained elusive.
In the context of ongoing budget talks, House Democrats urged President Barack Obama to maintain the Medicare program and stand firm against Republican efforts to cut the program's spending.
Researchers at The Queensland Institute of Medical Research (QIMR) have found that drugs used to treat HIV Aids may also be effective against the biggest killer in the world - malaria.
Through a few clever molecular hacks, researchers at Columbia University Medical Center have converted a natural bacterial immune system into a microscopic data recorder, laying the groundwork for a new class of technologies that use bacterial cells for everything from disease diagnosis to environmental monitoring.
Novartis announced today that Tafinlar (dabrafenib) + Mekinist (trametinib), the first oral combination therapy to be licensed for advanced melanoma, is now available in the UK for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.
› Verified 4 days ago
Entity Name | Morrow County Health District |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1376572099 PECOS PAC ID: 2365359296 Enrollment ID: O20061104000545 |
News Archive
With only incremental improvements in ovarian cancer survival over the last 40 years, there is a clear need for new treatment options with long-lasting results. Many researchers have turned toward the development of immunotherapies that direct T-cells to selectively eliminate ovarian tumor cells, but an appropriate therapeutic target for ovarian cancers has remained elusive.
In the context of ongoing budget talks, House Democrats urged President Barack Obama to maintain the Medicare program and stand firm against Republican efforts to cut the program's spending.
Researchers at The Queensland Institute of Medical Research (QIMR) have found that drugs used to treat HIV Aids may also be effective against the biggest killer in the world - malaria.
Through a few clever molecular hacks, researchers at Columbia University Medical Center have converted a natural bacterial immune system into a microscopic data recorder, laying the groundwork for a new class of technologies that use bacterial cells for everything from disease diagnosis to environmental monitoring.
Novartis announced today that Tafinlar (dabrafenib) + Mekinist (trametinib), the first oral combination therapy to be licensed for advanced melanoma, is now available in the UK for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.
› Verified 4 days ago
Entity Name | Bend Memorial Clinic Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699827477 PECOS PAC ID: 7214936533 Enrollment ID: O20061215000022 |
News Archive
With only incremental improvements in ovarian cancer survival over the last 40 years, there is a clear need for new treatment options with long-lasting results. Many researchers have turned toward the development of immunotherapies that direct T-cells to selectively eliminate ovarian tumor cells, but an appropriate therapeutic target for ovarian cancers has remained elusive.
In the context of ongoing budget talks, House Democrats urged President Barack Obama to maintain the Medicare program and stand firm against Republican efforts to cut the program's spending.
Researchers at The Queensland Institute of Medical Research (QIMR) have found that drugs used to treat HIV Aids may also be effective against the biggest killer in the world - malaria.
Through a few clever molecular hacks, researchers at Columbia University Medical Center have converted a natural bacterial immune system into a microscopic data recorder, laying the groundwork for a new class of technologies that use bacterial cells for everything from disease diagnosis to environmental monitoring.
Novartis announced today that Tafinlar (dabrafenib) + Mekinist (trametinib), the first oral combination therapy to be licensed for advanced melanoma, is now available in the UK for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.
› Verified 4 days ago
Entity Name | Cascade Medical Imaging Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932621588 PECOS PAC ID: 9537140108 Enrollment ID: O20171009003041 |
News Archive
With only incremental improvements in ovarian cancer survival over the last 40 years, there is a clear need for new treatment options with long-lasting results. Many researchers have turned toward the development of immunotherapies that direct T-cells to selectively eliminate ovarian tumor cells, but an appropriate therapeutic target for ovarian cancers has remained elusive.
In the context of ongoing budget talks, House Democrats urged President Barack Obama to maintain the Medicare program and stand firm against Republican efforts to cut the program's spending.
Researchers at The Queensland Institute of Medical Research (QIMR) have found that drugs used to treat HIV Aids may also be effective against the biggest killer in the world - malaria.
Through a few clever molecular hacks, researchers at Columbia University Medical Center have converted a natural bacterial immune system into a microscopic data recorder, laying the groundwork for a new class of technologies that use bacterial cells for everything from disease diagnosis to environmental monitoring.
Novartis announced today that Tafinlar (dabrafenib) + Mekinist (trametinib), the first oral combination therapy to be licensed for advanced melanoma, is now available in the UK for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.
› Verified 4 days ago
Entity Name | Central Oregon Magnetic Resonance Imaging Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114972155 PECOS PAC ID: 8224058003 Enrollment ID: O20171018001990 |
News Archive
With only incremental improvements in ovarian cancer survival over the last 40 years, there is a clear need for new treatment options with long-lasting results. Many researchers have turned toward the development of immunotherapies that direct T-cells to selectively eliminate ovarian tumor cells, but an appropriate therapeutic target for ovarian cancers has remained elusive.
In the context of ongoing budget talks, House Democrats urged President Barack Obama to maintain the Medicare program and stand firm against Republican efforts to cut the program's spending.
Researchers at The Queensland Institute of Medical Research (QIMR) have found that drugs used to treat HIV Aids may also be effective against the biggest killer in the world - malaria.
Through a few clever molecular hacks, researchers at Columbia University Medical Center have converted a natural bacterial immune system into a microscopic data recorder, laying the groundwork for a new class of technologies that use bacterial cells for everything from disease diagnosis to environmental monitoring.
Novartis announced today that Tafinlar (dabrafenib) + Mekinist (trametinib), the first oral combination therapy to be licensed for advanced melanoma, is now available in the UK for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Ryan E Berecky, MD 1460 Ne Medical Center Dr, Bend, OR 97701-6061 Ph: (541) 382-6633 | Ryan E Berecky, MD 1460 Ne Medical Center Dr, Bend, OR 97701-6061 Ph: (541) 382-6633 |
News Archive
With only incremental improvements in ovarian cancer survival over the last 40 years, there is a clear need for new treatment options with long-lasting results. Many researchers have turned toward the development of immunotherapies that direct T-cells to selectively eliminate ovarian tumor cells, but an appropriate therapeutic target for ovarian cancers has remained elusive.
In the context of ongoing budget talks, House Democrats urged President Barack Obama to maintain the Medicare program and stand firm against Republican efforts to cut the program's spending.
Researchers at The Queensland Institute of Medical Research (QIMR) have found that drugs used to treat HIV Aids may also be effective against the biggest killer in the world - malaria.
Through a few clever molecular hacks, researchers at Columbia University Medical Center have converted a natural bacterial immune system into a microscopic data recorder, laying the groundwork for a new class of technologies that use bacterial cells for everything from disease diagnosis to environmental monitoring.
Novartis announced today that Tafinlar (dabrafenib) + Mekinist (trametinib), the first oral combination therapy to be licensed for advanced melanoma, is now available in the UK for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.
› Verified 4 days ago
Dr. Nicholas Song Boehling, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-5800 Fax: 541-706-6341 | |
Dr. Casey George Curran, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1460 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-6633 Fax: 541-382-2719 | |
Dr. Brant David Wommack, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1460 Ne Medical Ctr Dr, Bend, OR 97701 Phone: 541-382-6633 Fax: 541-382-2719 | |
Richard Rotondi, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2052 Ne 4th St, Bend, OR 97701 Phone: 541-280-2789 | |
Dr. Jeremy James Logan, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1460 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-6633 Fax: 541-383-4577 | |
Steven Dean Kjobech, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1460 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-6633 Fax: 541-382-2719 | |
Dr. David Krieves, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1460 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-6633 Fax: 541-382-9327 |